• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MRA techniques without contrast address NSF fears

Article

Noncontrast MR angiography sequences could one day replace conventional contrast-enhanced MRA for evaluation of major arteries and veins of the thoracic region. They may provide an alternative for patients who risk developing nephrogenic systemic fibrosis and other contrast-related complications.

Noncontrast MR angiography sequences could one day replace conventional contrast-enhanced MRA for evaluation of major arteries and veins of the thoracic region. They may provide an alternative for patients who risk developing nephrogenic systemic fibrosis and other contrast-related complications.

Dr. Anderanik Tomasian, a radiologist at the University of California, Los Angeles, and colleagues enrolled 30 consecutive patients with known or suspected disease who underwent free-breathing ECG-gated steady-state free precession noncontrast MRA and high-resolution 3D contrast-enhanced MRA of the thorax, both at 1.5T. They found that noncontrast MRA allowed diagnosis of aortic thrombosis, dilatation, coarctation, and dissection as well as diagnosis of superior and inferior vena cava conditions. Total scanning time with this sequence ranged from five to 10 minutes.

Tomasian presented the data at the 2007 North American Society for Cardiac Imaging meeting in Washington, DC.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.